318 related articles for article (PubMed ID: 18005256)
21. Molecular dynamics simulations of human LRH-1: the impact of ligand binding in a constitutively active nuclear receptor.
Burendahl S; Treuter E; Nilsson L
Biochemistry; 2008 May; 47(18):5205-15. PubMed ID: 18410128
[TBL] [Abstract][Full Text] [Related]
22. Simulation of the different biological activities of diethylstilbestrol (DES) on estrogen receptor alpha and estrogen-related receptor gamma.
Nam K; Marshall P; Wolf RM; Cornell W
Biopolymers; 2003 Jan; 68(1):130-8. PubMed ID: 12579585
[TBL] [Abstract][Full Text] [Related]
23. Novel method for evaluation of chemicals based on ligand-dependent recruitment of GFP labeled coactivator to estrogen receptor displayed on bacterial magnetic particles.
Yoshino T; Kaji C; Nakai M; Saito F; Takeyama H; Matsunaga T
Anal Chim Acta; 2008 Sep; 626(1):71-7. PubMed ID: 18761123
[TBL] [Abstract][Full Text] [Related]
24. Structural determination of estrogen-related receptor gamma in the presence of phenol derivative compounds.
Abad MC; Askari H; O'Neill J; Klinger AL; Milligan C; Lewandowski F; Springer B; Spurlino J; Rentzeperis D
J Steroid Biochem Mol Biol; 2008 Jan; 108(1-2):44-54. PubMed ID: 17964775
[TBL] [Abstract][Full Text] [Related]
25. Highly potent binding and inverse agonist activity of bisphenol A derivatives for retinoid-related orphan nuclear receptor RORγ.
Nishigori M; Nose T; Shimohigashi Y
Toxicol Lett; 2012 Jul; 212(2):205-11. PubMed ID: 22659100
[TBL] [Abstract][Full Text] [Related]
26. Weak estrogenic transcriptional activities of Bisphenol A and Bisphenol S.
Grignard E; Lapenna S; Bremer S
Toxicol In Vitro; 2012 Aug; 26(5):727-31. PubMed ID: 22507746
[TBL] [Abstract][Full Text] [Related]
27. The binding of propranolol at 5-hydroxytryptamine1D beta T355N mutant receptors may involve formation of two hydrogen bonds to asparagine.
Glennon RA; Dukat M; Westkaemper RB; Ismaiel AM; Izzarelli DG; Parker EM
Mol Pharmacol; 1996 Jan; 49(1):198-206. PubMed ID: 8569707
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of 17alpha-20E-21-(4-substituted phenyl)-19-norpregna-1,3,5(10),20-tetraene-3,17beta-diols as probes for the estrogen receptor alpha hormone binding domain.
Hanson RN; Lee CY; Friel CJ; Dilis R; Hughes A; DeSombre ER
J Med Chem; 2003 Jul; 46(14):2865-76. PubMed ID: 12825929
[TBL] [Abstract][Full Text] [Related]
29. Ab initio quantum mechanical study of the binding energies of human estrogen receptor alpha with its ligands: an application of fragment molecular orbital method.
Fukuzawa K; Kitaura K; Uebayasi M; Nakata K; Kaminuma T; Nakano T
J Comput Chem; 2005 Jan; 26(1):1-10. PubMed ID: 15521089
[TBL] [Abstract][Full Text] [Related]
30. Novel estrogen receptor (ER) modulators: carbamate and thiocarbamate derivatives with m-carborane bisphenol structure.
Ohta K; Ogawa T; Suzuki T; Ohta S; Endo Y
Bioorg Med Chem; 2009 Dec; 17(23):7958-63. PubMed ID: 19857971
[TBL] [Abstract][Full Text] [Related]
31. A family-based approach reveals the function of residues in the nuclear receptor ligand-binding domain.
Folkertsma S; van Noort P; Van Durme J; Joosten HJ; Bettler E; Fleuren W; Oliveira L; Horn F; de Vlieg J; Vriend G
J Mol Biol; 2004 Aug; 341(2):321-35. PubMed ID: 15276826
[TBL] [Abstract][Full Text] [Related]
32. Understanding the human estrogen receptor-alpha using targeted mutagenesis.
Skafar DF; Koide S
Mol Cell Endocrinol; 2006 Feb; 246(1-2):83-90. PubMed ID: 16442702
[TBL] [Abstract][Full Text] [Related]
33. Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor.
Fang H; Tong W; Branham WS; Moland CL; Dial SL; Hong H; Xie Q; Perkins R; Owens W; Sheehan DM
Chem Res Toxicol; 2003 Oct; 16(10):1338-58. PubMed ID: 14565775
[TBL] [Abstract][Full Text] [Related]
34. Residues in the hydrophilic face of putative helix 8 of oxytocin receptor are important for receptor function.
Zhong M; Navratil AM; Clay C; Sanborn BM
Biochemistry; 2004 Mar; 43(12):3490-8. PubMed ID: 15035619
[TBL] [Abstract][Full Text] [Related]
35. Monitoring ligand modulation of protein-protein interactions by mass spectrometry: estrogen receptor alpha-SRC1.
Bovet C; Ruff M; Eiler S; Granger F; Wenzel R; Nazabal A; Moras D; Zenobi R
Anal Chem; 2008 Oct; 80(20):7833-9. PubMed ID: 18778086
[TBL] [Abstract][Full Text] [Related]
36. In silico binding of 4,4'-bisphenols predicts in vitro estrogenic and antiandrogenic activity.
Conroy-Ben O; Garcia I; Teske SS
Environ Toxicol; 2018 May; 33(5):569-578. PubMed ID: 29392883
[TBL] [Abstract][Full Text] [Related]
37. Evolutionary identification of a subtype specific functional site in the ligand binding domain of steroid receptors.
Raviscioni M; He Q; Salicru EM; Smith CL; Lichtarge O
Proteins; 2006 Sep; 64(4):1046-57. PubMed ID: 16835908
[TBL] [Abstract][Full Text] [Related]
38. Fate of bisphenol A during treatment with the litter-decomposing fungi Stropharia rugosoannulata and Stropharia coronilla.
Kabiersch G; Rajasärkkä J; Ullrich R; Tuomela M; Hofrichter M; Virta M; Hatakka A; Steffen K
Chemosphere; 2011 Apr; 83(3):226-32. PubMed ID: 21295326
[TBL] [Abstract][Full Text] [Related]
39. Crystal structure of a glutamate/aspartate binding protein complexed with a glutamate molecule: structural basis of ligand specificity at atomic resolution.
Hu Y; Fan CP; Fu G; Zhu D; Jin Q; Wang DC
J Mol Biol; 2008 Sep; 382(1):99-111. PubMed ID: 18640128
[TBL] [Abstract][Full Text] [Related]
40. In vitro study on the agonistic and antagonistic activities of bisphenol-S and other bisphenol-A congeners and derivatives via nuclear receptors.
Molina-Molina JM; Amaya E; Grimaldi M; Sáenz JM; Real M; Fernández MF; Balaguer P; Olea N
Toxicol Appl Pharmacol; 2013 Oct; 272(1):127-36. PubMed ID: 23714657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
